

FT News Briefing
Financial Times
A rundown of the most important global business stories you need to know for the coming day, from the newsroom of the Financial Times. Available every weekday morning. Hosted on Acast. See acast.com/privacy for more information.
Episodes
Mentioned books

Dec 7, 2020 • 8min
Brexit trade talks on a knife-edge, Brussels urged to heed climate science, Covid vaccines in India
Britain's trade talks with the EU are hanging in the balance, showcasing the ongoing tensions post-Brexit. There are urgent calls for Brussels to prioritize climate science in sustainable finance rules. Meanwhile, the AstraZeneca vaccine could soon be available for purchase in India, raising questions about vaccine access. Insights from Brussels reveal how the UK's departure influences future European dynamics, particularly in policymaking and budgetary matters.

Dec 4, 2020 • 10min
Brussels’s EU budget warning, Macron complicates Brexit deal, the ‘everything’ market rally
Brussels warns Poland and Hungary about potential cuts to their recovery funds due to rule of law issues. Macron complicates Brexit negotiations with last-minute demands, affecting the deal's stability. On the aviation front, Boeing celebrates its first order for the 737 MAX in nearly two years. Meanwhile, a global equity rally takes center stage, fueled by optimism from vaccine rollouts, raising questions about sustainability in the face of potential market disruptions.

Dec 3, 2020 • 11min
Democrats support US stimulus plan, China invests in US tech, reaction to UK vaccine approval
Top Democrats are showing flexibility in their support for a substantial $908 billion stimulus plan. The UK has made headlines by becoming the first country to approve a Covid-19 vaccine, sparking discussions on regulatory decisions. Meanwhile, Chinese investments in U.S. technology continue amidst tightening trade restrictions. Additionally, Nigeria's wealthiest individuals are reportedly increasing their stakes in the country's economy, reflecting a shift towards local investments despite significant economic challenges.

Dec 2, 2020 • 9min
Airbnb IPO pricing, EU squeezes UK in Brexit talks, Brazil's economy during the pandemic
Airbnb plans to raise up to $2.5 billion in its IPO, navigating pandemic challenges while aiming to boost its growth narrative. The ongoing Brexit negotiations remain tense, with the EU still withholding crucial rights from the UK. Meanwhile, Brazil faces significant economic struggles during the pandemic, grappling with high debt and the consequences of welfare spending. The discussion highlights the critical need for structural reforms to maintain fiscal stability while ensuring public support.

Dec 1, 2020 • 9min
Understanding eurozone inflation, Zoom sales up, Mnuchin and Powell testify before US Congress
Explore the rising costs of everyday goods in the eurozone, which are outpacing overall inflation. Discover how Zoom's revenues skyrocketed as remote work remains a staple. Learn about the landmark agreement among Eurozone finance ministers to bolster bailout strategies. Gain insights into the U.S. economic outlook as key officials prepare to testify before Congress, addressing pandemic-related challenges and future stimulus efforts.

Nov 30, 2020 • 11min
EU pitches post-Trump alliance with US, Covid-19 vaccine rollout, Lam’s cash problem
The EU is seizing a unique chance to rebuild its alliance with the US, aiming to tackle global challenges together. Excitement is building as the first Covid-19 vaccine prepares for international distribution. Meanwhile, Hong Kong's leader reveals she's hoarding cash due to US sanctions, shining a light on her financial struggles. Additionally, the UK is positioning itself as a global defense leader post-Brexit, with significant funding boosts and bold initiatives like a cyber force and advancements in military AI.

Nov 27, 2020 • 10min
Is AI finally closing in on human intelligence?
John Thornhill, the Innovation editor at the Financial Times, dives into the transformative potential of GPT-3, OpenAI's powerful language generation model. He highlights its ability to generate coherent text rapidly but warns of its limitations, including the challenges of context and risks of misuse. Thornhill discusses the impact of AI on job roles, especially in journalism, balancing the innovations with concerns about trustworthiness in AI-generated content. A captivating exploration of AI's double-edged sword in today's workforce!

Nov 26, 2020 • 9min
Brexit financial services woes, Salesforce eyes Slack, Facebook’s ad troubles
The podcast dives into the turbulent state of Europe's financial sector as Brexit's deadlines loom. There's a spotlight on Salesforce's potential multi-billion-dollar acquisition of Slack, and how it might reshape the cloud software arena. The conversation also brings to light Facebook's controversy over misleading ads in the UK, revealing the regulatory challenges it faced. Meanwhile, UK Chancellor Rishi Sunak raises alarms about a looming economic emergency, accentuating the nation's fiscal woes and record-high borrowing.

Nov 25, 2020 • 10min
Markets rise on White House transition, France taxes US tech giants, bank dividends
US stocks hit record highs amid investor optimism following the election. Meanwhile, France is enforcing digital taxes on American tech giants, stirring tensions over trade practices. Eurozone banks may soon resume dividend payouts if their financials are solid, thanks to potential ECB support. On a cultural note, Japan faces hurdles in digitalizing its bureaucracy, largely due to the deep-rooted significance of traditional hanko stamps.

Nov 24, 2020 • 10min
Yellen likely choice for US Treasury, Peru’s century bonds, Oxford-AstraZeneca vaccine
President-elect Joe Biden is leaning towards appointing Janet Yellen as Treasury Secretary, a move that could shape the U.S. economy during challenging times. Peru has joined a select group of nations by issuing century bonds to tackle its financial hurdles. As Thanksgiving approaches, air travel in the U.S. is increasing, defying health warnings. Meanwhile, optimism is rising around the Oxford-AstraZeneca vaccine, which could play a crucial role in the global fight against COVID-19.


